Practical Aspects of Vaccine Development – Ebook PDF Instant Delivery 1st Edition- ISBN(s): 9780128143575,0128143576,9780128143582, 0128143584
Product details:
- ISBN-10 : 0128143584
- ISBN-13 : 9780128143582
- Author: Satoshi Ohtake , Parag Kolhe
Practical Aspects of Vaccine Development provides an academic and industry perspective on vaccine development and manufacturing. With the increasing complexity of vaccine products in development, there is a need for a comprehensive review of the current state of the industry and challenges being encountered. While formulation scientists working in biotherapeutic development may be familiar with proteins, vaccines present unique challenges. Vaccines include a wide range of components including proteins, polysaccharides, protein-polysaccharide conjugates, adjuvants, and more. The container closure system may also be unique, and the product may require freezing storage or lyophilization based on the stability of the vaccine components. Based on the route of delivery, novel technologies and devices may be required.
Table of contents:
1 – Introduction to vaccine development
2 – Overview of vaccine adjuvants
3 – Formulation design considerations and good practice for live attenuated vaccine development
4 – Subunit-based vaccines: challenges in developing protein-based vaccines
5 – QbD approach to formulation development for protein-based vaccines
6 – pDNA and mRNA vaccines
7 – Antigen–adjuvant formulations—key considerations
8 – Suspension properties and characterization of aluminum-adjuvanted vaccines
9 – Effect of shipping stresses on suspension vaccines
10 – Control strategy development guide for vaccine drug product
11 – Lyophilized vaccine development
12 – Conventional and nontraditional delivery methods and routes of vaccine administration
People also search:
what is vaccine development
are they developing new covid vaccines
is the development of an anti-cancer vaccine possible
development of an inactivated vaccine candidate for sars-cov-2
towards the development of an epitope-focused vaccine for sars-cov-2